|
Nov 1
|
Prelude Therapeutics and AbCellera Enter Partnership to Develop First-in-Class Precision Antibody Drug Conjugates in Oncology
|
|
Oct 31
|
AbCellera to Present at the Jefferies London Healthcare Conference on November 14, 2023
|
|
Apr 27
|
AbCellera Biologics Inc. (ABCL) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
|
|
Apr 24
|
7 Stocks Under $10 That Analysts Love
|
|
Mar 22
|
AbCellera and RQ Bio Partner to Accelerate the Advancement of New Therapies for Infectious Disease
|